Connect with us

National

Hwange to host regional summit on ivory trade ban

Published

on

BY NOKUTHABA DLAMINI

Zimbabwe will this month hold a regional summit to discuss a common position on the global ban on ivory trade as the countries battle to fund conservation activities and rising poaching activities.

Advertisement

The summit to be held in Hwange  between May 23 and 26 will be attended by environment and tourism ministers from the Southern African Development Community (Sadc).

Ministers from Zimbabwe, Botswana, Namibia, Zambia and Angola will attend the summit.

Zimbabwe Parks and Wildlife Management Authority (Zimparks) spokesperson Tinashe Farawo said the region wanted to speak with one voice on the ivory trade ban by the Convention on International Trade in Endangered Species (CITES), which has been in place since 1998.

Advertisement

“We want to build consensus around African countries to speak with one voice when it comes to conservation and safeguarding of our animals and the communities,” Farawo told VicFallsLive.

“We also want to find out on what is it that we can do in terms of dealing with our stockpile because as Zimbabwe, we are sitting on more than half a billion dollars of ivory.

“Issues around the lifting of the CITES ban will be extensively discussed so that at least our people can benefit as we try to also fight wildlife related crimes around the southern Africa region.”

Advertisement

He said African countries have failed to lobby against the ivory trade ban because of lack of a platform where there can speak with one voice at CITES gatherings.

“If we build consensus as Africans, when we go on an international wildlife forum undivided and our voices can outweigh the decision,” Farawo said.

“We also want to take stock of our failures and successes over the years as neighbouring countries and to also come up with strategies and methods of how-to carry out conservation, to deal with climate change and poaching”

Advertisement

In 2019, Zimparks reported that more than 200 elephants and other wildlife species at the country’s game parks died due to drought.

The authority says its failure to dispose of its huge ivory stockpiles has left it unable to fund conservation activities and also to mitigate against the effects of climate change.

“Almost every animal is being affected by this ban,” Farawo said.

Advertisement

He said an increasing number of animals were straying from game reserves into nearby communities in search of food and water leading to cases of human-wildlife conflicts that resulted in the death of 71 people last year alone.

Stevenson Dhlamini, an economic analyst from the National University of Science and Technology, said the forthcoming summit could unlock opportunities for the country’s economy.

“Also, this move will go a long way in ensuring that the population growth of elephants is manageable,” Dhlamini said.

Advertisement

“The communities will also benefit from the influx of tourists into their communities, which results in economic empowerment.

“Again, the lifting of the ban will ensure that the blanket approach to environmental protection does not result in an unfair effect on the communities who do not have the capacity to sustain larger elephant populations which then strains the ecosystem.”

Zimbabwe has an estimated elephant population of 85 000, which is the second largest in Africa after second only to neighbouring Botswana with more than 130 000.

Advertisement

The southern African country has been exporting live elephants to countries such as China and authorities say this is one of the ways of controlling their population and also to raise money for conservation.

Between 2016 and this year Zimbabwe exported about 100 elephants, mainly to China and the United Arab Emirates and raised more than US$3 million.

There have also been suggestions that the country must start culling elephants.

Advertisement

The country last culled elephants in 1988 and continues to have stockpiles of ivory which it cannot sell because of restrictions.

Advertisement

National

World AIDS Day: UN Chief says ending AIDS by 2030 “is within grasp”

Published

on

BY SONIA HLOPHE

United Nations Secretary-General António Guterres has marked World AIDS Day with a message urging world leaders to scale up investment, confront stigma and ensure that lifesaving HIV services reach everyone who needs them.

Advertisement

In his statement, Guterres said this year’s commemoration serves as a reminder that the world “has the power to transform lives and futures, and end the AIDS epidemic once and for all.”

He highlighted the major gains achieved over the past decade.

“The progress we have made is undeniable,” he said, noting that “since 2010, new infections have fallen by 40 per cent” while “AIDS-related deaths have declined by more than half.” Access to treatment, he added, “is better than ever before.”

Advertisement

But despite this global progress, the Secretary-General warned that the crisis is far from over.

“For many people around the world, the crisis continues,” he said. “Millions still lack access to HIV prevention and treatment services because of who they are, where they live or the stigma they endure.”

Guterres also raised concern over shrinking resources:

Advertisement

“Reduced resources and services are putting lives at risk and threatening hard-won gains.”

He said ending AIDS requires fully supporting communities, scaling up prevention and ensuring treatment for everyone.

“Ending AIDS means empowering communities, investing in prevention and expanding access to treatment for all people.”

Advertisement

He also called for innovation to be matched by real-world delivery:

“It means uniting innovation with action, and ensuring new tools like injectables reach more people in need.”

Above all, he stressed the need for a human-rights centred response so no one is excluded.

Advertisement

“At every step, it means grounding our work in human rights to ensure no one is left behind.”

With the 2030 global deadline approaching, the UN chief said success is still possible if momentum is sustained.

“Ending AIDS as a public health threat by 2030 is within grasp. Let’s get the job done.”

Advertisement

 

Advertisement
Continue Reading

National

Zimbabwe fast-tracks approval of long-acting HIV prevention drug Lenacapavir

Published

on

BY WANDILE TSHUMA

Zimbabwe has taken a major step in the fight against HIV following the rapid approval of Lenacapavir, a groundbreaking long-acting injectable for HIV pre-exposure prophylaxis (PrEP). The Medicines Control Authority of Zimbabwe (MCAZ) authorised the drug in just 23 days, marking one of the fastest regulatory approvals in the country’s history.

Advertisement

The application, submitted by pharmaceutical company Gilead Sciences in October, underwent an expedited review because of its public health importance. MCAZ says the fast-tracked process did not compromise scientific scrutiny, with the product subjected to a rigorous assessment of its safety, efficacy and quality.

Lenacapavir is designed for adults and adolescents weighing at least 35kg who are HIV-negative but at substantial risk of infection. Unlike traditional daily oral PrEP, the medicine is administered as a six-monthly injection, following an initiation phase that includes one injection and oral tablets on Days 1 and 2. Health authorities say this long-acting formulation could dramatically improve adherence and expand prevention options, particularly for communities where daily pill-taking is difficult.

MCAZ Director-General  Richard T. Rukwata described the approval as a landmark moment in Zimbabwe’s HIV response.

Advertisement

“The rapid approval of Lenacapavir reflects MCAZ’s dedication to accelerating access to trusted, high-quality health products. This milestone brings new hope for HIV prevention and reinforces our commitment to safeguarding public health,” he said.

To fast-track the process, the Authority applied a regulatory reliance approach, drawing on scientific assessments from the World Health Organization’s Prequalification Programme (WHO PQ). This allowed evaluators to build on internationally recognised review processes while ensuring Zimbabwe’s own standards were met.

The introduction of Lenacapavir comes as Zimbabwe continues efforts to reduce new HIV infections, particularly among young people and key populations who face barriers to consistent PrEP use. Public health experts say the drug’s twice-yearly dosing could be a game changer in improving uptake and protection.

Advertisement

MCAZ says it remains committed to ensuring Zimbabweans have access to safe, effective and good-quality medical products, in line with its mandate under the Medicines and Allied Substances Control Act.

Advertisement
Continue Reading

National

Zimbabwe makes gains against TB

Published

on

BY WANDILE TSHUMA

The World Health Organization (WHO) data show that Zimbabwe continues to make measurable gains in its fight against tuberculosis (TB).

Advertisement

According to the Global Tuberculosis Report 2025, Zimbabwe’s estimated TB incidence has declined to 203 per 100,000 population, representing a 3.8 % reduction from 2023. The report states that “TB incidence in Zimbabwe has fallen to 203 per 100 000, a 3.8 % reduction from 2023.” 

On treatment outcomes, the country’s overall success rate for all forms of TB has improved to 91 %, up from 89 % in 2023. The report quotes: “Treatment success for all forms of TB has improved to 91 %, up from 89 % in 2023.” 

For drug-resistant TB (DR-TB), progress has also been recorded: treatment success rose from 64 % for the 2021 cohort to 68 % for the 2022 cohort. As the report notes: “treatment success for drug-resistant TB increased from 64 % for the 2021 cohort to 68 % for the 2022 cohort.” 

Advertisement

In the critical sphere of TB‐HIV co-infection, Zimbabwe saw a drop in the co‐infection rate to 49 %, down from 51 %. The report states: “TB/HIV co-infection rates have fallen to 49 %, down from 51 %.” 

Zooming out, the 2025 global report shows that across the world TB is falling again, although not yet at the pace required to meet targets. Globally, incidence declined by almost 2 % between 2023 and 2024, and deaths fell around 3 %. 

However, the report warns that progress is fragile. Funding shortfalls, health-system disruptions (especially during the COVID-19 era), and the ongoing challenge of drug-resistant TB threaten to erode gains. The WHO page reminds that the 2025 edition “provides a comprehensive … assessment of the TB epidemic … at global, regional and country levels.” 

Advertisement

For example, although more people are being diagnosed and treated than in previous years, not enough are being reached with preventive interventions, and many countries are still far from the targets set under the End TB Strategy.

 

Advertisement
Continue Reading

Trending

Copyright © 2022 VicFallsLive. All rights reserved, powered by Advantage